Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease

Identifieur interne : 000634 ( PascalFrancis/Corpus ); précédent : 000633; suivant : 000635

Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease

Auteurs : Caroline Moreau ; Odile Pennel-Ployart ; Serge Pinto ; Audrey Plachez ; Agnes Annic ; François Viallet ; Alain Destee ; Luc Defebvre

Source :

RBID : Pascal:11-0228395

Descripteurs français

English descriptors

Abstract

Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 26
A06       @2 4
A08 01  1  ENG  @1 Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease
A11 01  1    @1 MOREAU (Caroline)
A11 02  1    @1 PENNEL-PLOYART (Odile)
A11 03  1    @1 PINTO (Serge)
A11 04  1    @1 PLACHEZ (Audrey)
A11 05  1    @1 ANNIC (Agnes)
A11 06  1    @1 VIALLET (François)
A11 07  1    @1 DESTEE (Alain)
A11 08  1    @1 DEFEBVRE (Luc)
A14 01      @1 Service de neurologie et pathologie du mouvement, Université Lille Nord de France @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut. @Z 7 aut. @Z 8 aut.
A14 02      @1 Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence @3 FRA @Z 3 aut. @Z 6 aut.
A14 03      @1 Service de neurologie, Centre Hospitalier du Pays d'Aix @2 Aix-en-Provence @3 FRA @Z 6 aut.
A20       @1 659-663
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000189767540130
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 18 ref.
A47 01  1    @0 11-0228395
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Maladie de Parkinson @2 NM @5 01
C03 01  X  ENG  @0 Parkinson disease @2 NM @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @2 NM @5 01
C03 02  X  FRE  @0 Dysarthrie @5 02
C03 02  X  ENG  @0 Dysarthria @5 02
C03 02  X  SPA  @0 Disartria @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Modulation @5 09
C03 04  X  ENG  @0 Modulation @5 09
C03 04  X  SPA  @0 Modulación @5 09
C03 05  X  FRE  @0 Basse fréquence @5 10
C03 05  X  ENG  @0 Low frequency @5 10
C03 05  X  SPA  @0 Baja frecuencia @5 10
C03 06  X  FRE  @0 Stade avancé @5 11
C03 06  X  ENG  @0 Advanced stage @5 11
C03 06  X  SPA  @0 Estadio avanzado @5 11
C03 07  X  FRE  @0 Noyau sousthalamique @5 12
C03 07  X  ENG  @0 Subthalamic nucleus @5 12
C03 07  X  SPA  @0 Núcleo subtalámico @5 12
C03 08  X  FRE  @0 Stimulation cérébrale profonde @4 CD @5 96
C03 08  X  ENG  @0 Deep brain stimulation @4 CD @5 96
C07 01  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Syndrome extrapyramidal @5 38
C07 02  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 02  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 03  X  FRE  @0 Maladie dégénérative @5 39
C07 03  X  ENG  @0 Degenerative disease @5 39
C07 03  X  SPA  @0 Enfermedad degenerativa @5 39
C07 04  X  FRE  @0 Pathologie du système nerveux central @5 40
C07 04  X  ENG  @0 Central nervous system disease @5 40
C07 04  X  SPA  @0 Sistema nervosio central patología @5 40
C07 05  X  FRE  @0 Trouble de la communication @5 42
C07 05  X  ENG  @0 Communication disorder @5 42
C07 05  X  SPA  @0 Trastorno comunicación @5 42
C07 06  X  FRE  @0 Trouble du langage @5 43
C07 06  X  ENG  @0 Language disorder @5 43
C07 06  X  SPA  @0 Trastorno lenguaje @5 43
C07 07  X  FRE  @0 Trouble neurologique @5 44
C07 07  X  ENG  @0 Neurological disorder @5 44
C07 07  X  SPA  @0 Trastorno neurológico @5 44
C07 08  X  FRE  @0 Encéphale @5 45
C07 08  X  ENG  @0 Encephalon @5 45
C07 08  X  SPA  @0 Encéfalo @5 45
C07 09  X  FRE  @0 Système nerveux central @5 46
C07 09  X  ENG  @0 Central nervous system @5 46
C07 09  X  SPA  @0 Sistema nervioso central @5 46
N21       @1 150
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0228395 INIST
ET : Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease
AU : MOREAU (Caroline); PENNEL-PLOYART (Odile); PINTO (Serge); PLACHEZ (Audrey); ANNIC (Agnes); VIALLET (François); DESTEE (Alain); DEFEBVRE (Luc)
AF : Service de neurologie et pathologie du mouvement, Université Lille Nord de France/France (1 aut., 2 aut., 4 aut., 5 aut., 7 aut., 8 aut.); Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence/France (3 aut., 6 aut.); Service de neurologie, Centre Hospitalier du Pays d'Aix/Aix-en-Provence/France (6 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 4; Pp. 659-663; Bibl. 18 ref.
LA : Anglais
EA : Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.
CC : 002B17; 002B17G
FD : Maladie de Parkinson; Dysarthrie; Pathologie du système nerveux; Modulation; Basse fréquence; Stade avancé; Noyau sousthalamique; Stimulation cérébrale profonde
FG : Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Trouble de la communication; Trouble du langage; Trouble neurologique; Encéphale; Système nerveux central
ED : Parkinson disease; Dysarthria; Nervous system diseases; Modulation; Low frequency; Advanced stage; Subthalamic nucleus; Deep brain stimulation
EG : Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Communication disorder; Language disorder; Neurological disorder; Encephalon; Central nervous system
SD : Parkinson enfermedad; Disartria; Sistema nervioso patología; Modulación; Baja frecuencia; Estadio avanzado; Núcleo subtalámico
LO : INIST-20953.354000189767540130
ID : 11-0228395

Links to Exploration step

Pascal:11-0228395

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease</title>
<author>
<name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pennel Ployart, Odile" sort="Pennel Ployart, Odile" uniqKey="Pennel Ployart O" first="Odile" last="Pennel-Ployart">Odile Pennel-Ployart</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pinto, Serge" sort="Pinto, Serge" uniqKey="Pinto S" first="Serge" last="Pinto">Serge Pinto</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Plachez, Audrey" sort="Plachez, Audrey" uniqKey="Plachez A" first="Audrey" last="Plachez">Audrey Plachez</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Annic, Agnes" sort="Annic, Agnes" uniqKey="Annic A" first="Agnes" last="Annic">Agnes Annic</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Viallet, Francois" sort="Viallet, Francois" uniqKey="Viallet F" first="François" last="Viallet">François Viallet</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Service de neurologie, Centre Hospitalier du Pays d'Aix</s1>
<s2>Aix-en-Provence</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destee">Alain Destee</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0228395</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0228395 INIST</idno>
<idno type="RBID">Pascal:11-0228395</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000634</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease</title>
<author>
<name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pennel Ployart, Odile" sort="Pennel Ployart, Odile" uniqKey="Pennel Ployart O" first="Odile" last="Pennel-Ployart">Odile Pennel-Ployart</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pinto, Serge" sort="Pinto, Serge" uniqKey="Pinto S" first="Serge" last="Pinto">Serge Pinto</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Plachez, Audrey" sort="Plachez, Audrey" uniqKey="Plachez A" first="Audrey" last="Plachez">Audrey Plachez</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Annic, Agnes" sort="Annic, Agnes" uniqKey="Annic A" first="Agnes" last="Annic">Agnes Annic</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Viallet, Francois" sort="Viallet, Francois" uniqKey="Viallet F" first="François" last="Viallet">François Viallet</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Service de neurologie, Centre Hospitalier du Pays d'Aix</s1>
<s2>Aix-en-Provence</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destee">Alain Destee</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Advanced stage</term>
<term>Deep brain stimulation</term>
<term>Dysarthria</term>
<term>Low frequency</term>
<term>Modulation</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Subthalamic nucleus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Maladie de Parkinson</term>
<term>Dysarthrie</term>
<term>Pathologie du système nerveux</term>
<term>Modulation</term>
<term>Basse fréquence</term>
<term>Stade avancé</term>
<term>Noyau sousthalamique</term>
<term>Stimulation cérébrale profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>26</s2>
</fA05>
<fA06>
<s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MOREAU (Caroline)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>PENNEL-PLOYART (Odile)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PINTO (Serge)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>PLACHEZ (Audrey)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>ANNIC (Agnes)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>VIALLET (François)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DESTEE (Alain)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>DEFEBVRE (Luc)</s1>
</fA11>
<fA14 i1="01">
<s1>Service de neurologie et pathologie du mouvement, Université Lille Nord de France</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Service de neurologie, Centre Hospitalier du Pays d'Aix</s1>
<s2>Aix-en-Provence</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>659-663</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000189767540130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0228395</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Dysarthrie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Dysarthria</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Disartria</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Modulation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Modulation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Modulación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Basse fréquence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Low frequency</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Baja frecuencia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Stade avancé</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Advanced stage</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Estadio avanzado</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Noyau sousthalamique</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Subthalamic nucleus</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Núcleo subtalámico</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Stimulation cérébrale profonde</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Deep brain stimulation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Trouble de la communication</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Communication disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Trastorno comunicación</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Trouble du langage</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Language disorder</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Trastorno lenguaje</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Encéphale</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Encephalon</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Encéfalo</s0>
<s5>45</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Système nerveux central</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Central nervous system</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
<s5>46</s5>
</fC07>
<fN21>
<s1>150</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0228395 INIST</NO>
<ET>Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease</ET>
<AU>MOREAU (Caroline); PENNEL-PLOYART (Odile); PINTO (Serge); PLACHEZ (Audrey); ANNIC (Agnes); VIALLET (François); DESTEE (Alain); DEFEBVRE (Luc)</AU>
<AF>Service de neurologie et pathologie du mouvement, Université Lille Nord de France/France (1 aut., 2 aut., 4 aut., 5 aut., 7 aut., 8 aut.); Laboratoire Parole et Langage, UMR 6057 CNRS/Université de Provence, Aix-en-Provence/France (3 aut., 6 aut.); Service de neurologie, Centre Hospitalier du Pays d'Aix/Aix-en-Provence/France (6 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 4; Pp. 659-663; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear. Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS. Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit. Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Dysarthrie; Pathologie du système nerveux; Modulation; Basse fréquence; Stade avancé; Noyau sousthalamique; Stimulation cérébrale profonde</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Trouble de la communication; Trouble du langage; Trouble neurologique; Encéphale; Système nerveux central</FG>
<ED>Parkinson disease; Dysarthria; Nervous system diseases; Modulation; Low frequency; Advanced stage; Subthalamic nucleus; Deep brain stimulation</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Communication disorder; Language disorder; Neurological disorder; Encephalon; Central nervous system</EG>
<SD>Parkinson enfermedad; Disartria; Sistema nervioso patología; Modulación; Baja frecuencia; Estadio avanzado; Núcleo subtalámico</SD>
<LO>INIST-20953.354000189767540130</LO>
<ID>11-0228395</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000634 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000634 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0228395
   |texte=   Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson's Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024